Case number 2017-1344
Aptalis Pharmatech, Inc. v. Apotex Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Apr 23, 2021 | 0 | APTALIS PHARMATECH, INC. v. APOTEX INC. [OPINION] [nonprecedential] (0) |
| Apr 30, 2018 | 79 | Mandate issued to the United States District Court for the District of Delaware. Costs taxed in the amount of $2967.88. Service as of this date by the Clerk of Court. [517812] [SJ] [Entered: 04/30/2018 03:51 PM] (1) |
| Apr 23, 2018 | 78 | ORDER filed denying [72] petition for panel rehearing filed by Aptalis Pharmatech, Inc. and Ivax International GmbH; denying [72] petition for en banc rehearing filed by Aptalis Pharmatech, Inc. and Ivax International GmbH. By: En Banc (Per Curiam). Service as of this date by the Clerk of Court. [516122] [SJ] [Entered: 04/23/2018 03:00 PM] (2) |
| Apr 10, 2018 | 77 | 18 paper copies of the response [76] received from Appellants Apotex Corp. and Apotex Inc. [512039] [SJ] [Entered: 04/10/2018 11:39 AM] (0) |
| Apr 6, 2018 | 76 | RESPONSE of Appellants Apotex Corp. and Apotex Inc. to the petition for panel rehearing [72] filed by Appellees Aptalis Pharmatech, Inc. and Ivax International GmbH, petition for en banc rehearing [72] filed by Appellees Aptalis Pharmatech, Inc. and Ivax International GmbH. Service: 04/06/2018 by email. [511339] [17-1344] [William Zimmerman] [Entered: 04/06/2018 01:39 PM] (23) |
| Mar 23, 2018 | 75 | The court invites a response from Appellants Apotex Corp. and Apotex Inc. to the petition for panel rehearing filed by Appellees in 17-1344 , petition for en banc rehearing filed by Appellees in 17-1344. The response is due on or before 04/06/2018. [507545] [JAB] [Entered: 03/23/2018 12:57 PM] (1) |
| Feb 28, 2018 | 74 | 18 paper copies of the petition for panel rehearing [72], petition for en banc rehearing [72] received from Appellees Aptalis Pharmatech, Inc. and Ivax International GmbH. [501774] [SJ] [Entered: 02/28/2018 02:16 PM] (0) |
| Feb 27, 2018 | 73 | The party filed a corrected petition and is withdrawing [71] petition for en banc rehearing filed by Appellees Aptalis Pharmatech, Inc. and Ivax International GmbH; withdrawing [71] petition for panel rehearing filed by Appellees Aptalis Pharmatech, Inc. and Ivax International GmbH. The previously filed petition is withdrawn. [501232] [SJ] [Entered: 02/27/2018 08:34 AM] (0) |
| Feb 26, 2018 | 72 | Petition for panel rehearing, for en banc rehearing filed by Appellees Aptalis Pharmatech, Inc. and Ivax International GmbH. Service: 02/26/2018 by email. The paper copies of the petition must be filed within two business days (see Fed. Cir. R. 35(c)(4).The required paper copies should be received by the court on or before 02/28/2018 [501201] [John Lane] [Entered: 02/26/2018 06:16 PM] (40) |
| Feb 26, 2018 | 71 | Petition for en banc rehearing, for panel rehearing filed by Appellees Aptalis Pharmatech, Inc. and Ivax International GmbH. Service: 02/26/2018 by email. The paper copies of the petition must be filed within two business days (see Fed. Cir. R. 35(c)(4).The required paper copies should be received by the court on or before 02/28/2018 [501191] This petition has been REPLACED. [John Lane] [Entered: 02/26/2018 05:48 PM] (0) |
| Jan 18, 2018 | 70 | ORDER filed granting motion to extend time to file petition for rehearing [67] filed by Appellees Aptalis Pharmatech, Inc. and Ivax International GmbH. Petition for Rehearing due on or before 02/26/2018. By: Merits Panel (Per Curiam). Service as of this date by Clerk of Court. [490613] [SJ] [Entered: 01/18/2018 10:25 AM] (2) |
| Jan 17, 2018 | 69 | REPLY of Appellees Aptalis Pharmatech, Inc. and Ivax International GmbH to response filed by Appellants in 17-1344 , Doc. No [68]. Service: 01/17/2018 by email. [490478] [John Lane] [Entered: 01/17/2018 04:44 PM] (9) |
| Jan 16, 2018 | 68 | RESPONSE of Appellants Apotex Corp. and Apotex Inc. to the motion to extend time to file petition for rehearing [67] filed by Appellees Aptalis Pharmatech, Inc. and Ivax International GmbH in 17-1344. Service: 01/16/2018 by email. [489846] [William Zimmerman] [Entered: 01/16/2018 03:43 PM] (64) |
| Jan 12, 2018 | 67 | MOTION of Appellees Aptalis Pharmatech, Inc. and Ivax International GmbH to extend the time to file a Petition for Rehearing En Banc until 02/26/2018. [Consent: opposed]. Service: 01/12/2018 by email. [489390]--[Edited 01/12/2018 by clerk to correct date requested] [John Lane] [Entered: 01/12/2018 03:06 PM] (15) |
| Jan 12, 2018 | 66 | Bill of Costs for Appellants Apotex Corp. and Apotex Inc.. Service: 01/12/2018 by email. Objection to Bill of Costs due on 01/26/2018. [489353] [William Zimmerman] [Entered: 01/12/2018 02:24 PM] (0) |
| Jan 4, 2018 | 65 | OPINION and JUDGMENT filed. The judgment or decision is: Vacated and Remanded. (Nonprecedential Opinion). (For the Court: Reyna,Circuit Judge; Wallach,Circuit Judge and Stoll,Circuit Judge). [487270] [SJ] [Entered: 01/04/2018 10:10 AM] (16) |
| Dec 5, 2017 | 64 | Submitted after ORAL ARGUMENT by William R. Zimmerman for Apotex Inc. and Apotex Corp. and Mr. John R. Lane for Aptalis Pharmatech, Inc. and Ivax International GmbH. Panel: Judge: Reyna , Judge: Wallach , Judge: Stoll. [480245] [JCP] [Entered: 12/05/2017 10:36 AM] (0) |
| Nov 14, 2017 | 63 | Response to oral argument order from the Appellees Aptalis Pharmatech, Inc. and Ivax International GmbH. designating John C. Lane as arguing attorney. Designated time for argument: 15 minutes. Designated time for rebuttal: 0 minutes. Service of other counsel by Notice of Docket Activity from this entry. [475291] [John Lane] [Entered: 11/14/2017 12:05 PM] (0) |
| Nov 9, 2017 | 62 | Response to oral argument order from the Appellants Apotex Corp. and Apotex Inc.. designating William R. Zimmerman as arguing attorney. Designated time for argument: 12 minutes. Designated time for rebuttal: 3 minutes. Service of other counsel by Notice of Docket Activity from this entry. [474270] [William Zimmerman] [Entered: 11/09/2017 11:29 AM] (0) |
| Oct 20, 2017 | 61 | NOTICE OF CALENDARING. Panel: 1712F. Case scheduled Dec 05, 2017 10:00 a.m. at the United States Court of Appeals for the Federal Circuit (Howard T. Markey National Courts Building, 717 Madison Place, N.W. Washington, DC 20439), Courtroom 402. Response to oral argument order due: 11/15/2017. Arguing counsel is required to check-in with the Clerk's Office, 4th Floor, Room 401, between 8:30 a.m. and 9:30 a.m. on the day of argument. Please review the Oral Argument Order. [469387] [JAB] [Entered: 10/20/2017 12:11 PM] (0) |
| Jul 10, 2017 | 60 | Notice from Appellees Aptalis Pharmatech, Inc. and Ivax International GmbH regarding conflicts with oral argument (oral argument before Federal Circuit in October 2017 for another case). Service: 07/10/2017 by email. [445227] [Jonathan Singer] [Entered: 07/10/2017 01:35 PM] (2) |
| Jun 26, 2017 | 59 | 6 paper copies of the Corrected Confidential Joint Appendix in 12 Volumes [56] received from Appellants Apotex Corp. and Apotex Inc. [441930] [JCP] [Entered: 06/26/2017 10:25 AM] (0) |
| Jun 20, 2017 | 58 | Notice from Appellants Apotex Corp. and Apotex Inc. regarding conflicts with oral argument (Conflict on 9/5/17 due to Pre-booked family event). Service: 06/20/2017 by email. [440848] [William Zimmerman] [Entered: 06/20/2017 04:02 PM] (2) |
| Jun 19, 2017 | 55 | Notice from Appellees Aptalis Pharmatech, Inc. and Ivax International GmbH regarding conflicts with oral argument (Inter Partes Review hearings before PTAB; trial in USDC-TXED and post-trial motions in USDC-DE). Service: 06/19/2017 by email. [440306] [Jonathan Singer] [Entered: 06/19/2017 12:01 PM] (2) |
| Jun 16, 2017 | 57 | CORRECTED JOINT APPENDIX, VOLS. I - XII FILED for Apotex Corp. and Apotex Inc. [51]. Number of Pages: 659. Service: 06/16/2017 by email. [440820] [CAB] [Entered: 06/20/2017 03:16 PM] (659) |
| Jun 16, 2017 | 56 | CORRECTED CONFIDENTIAL JOINT APPENDIX, VOLS. I - XII FILED for Apotex Corp. and Apotex Inc. [52], [53], [54]. Number of Pages: 4396. Service: 06/16/2017 by email. The paper copies of the corrected confidential joint appendix should be received by the court on or before 06/27/2017. [440812] [CAB] [Entered: 06/20/2017 02:57 PM] (0) |
| Jun 16, 2017 | 54 | TENDERED from Appellants Apotex Corp., Apotex Inc. and Appellees Aptalis Pharmatech, Inc. and Ivax International GmbH. Title: CORRECTED CONFIDENTIAL JOINT APPENDIX Service: 06/16/2017 by email. [440148] [William Zimmerman] [Entered: 06/16/2017 08:02 PM] (0) |
| Jun 16, 2017 | 53 | TENDERED from Appellants Apotex Corp., Apotex Inc. and Appellees Aptalis Pharmatech, Inc. and Ivax International GmbH. Title: CORRECTED CONFIDENTIAL JOINT APPENDIX Service: 06/16/2017 by email. [440146] [William Zimmerman] [Entered: 06/16/2017 07:53 PM] (0) |
| Jun 16, 2017 | 52 | TENDERED from Appellants Apotex Corp., Apotex Inc. and Appellees Aptalis Pharmatech, Inc. and Ivax International GmbH. Title: CORRECTED CONFIDENTIAL JOINT APPENDIX Service: 06/16/2017 by email. [440143] [William Zimmerman] [Entered: 06/16/2017 07:20 PM] (0) |
| Jun 16, 2017 | 51 | TENDERED from Appellants Apotex Corp., Apotex Inc. and Appellees Aptalis Pharmatech, Inc. and Ivax International GmbH. Title: CORRECTED JOINT APPENDIX. Service: 06/16/2017 by email. [440141] [William Zimmerman] [Entered: 06/16/2017 07:13 PM] (659) |
| Jun 16, 2017 | 50 | Notice of Correction to the confidential Brief Doc No. [46], confidential Brief Doc No. [45], confidential Brief Doc No. [44], Brief Doc No. [43] for Appellants Apotex Corp. and Apotex Inc.. Service: 06/16/2017 by email. [440140] [William Zimmerman] [Entered: 06/16/2017 07:08 PM] (3) |
| Jun 16, 2017 | 49 | Pursuant to Practice Note 34, counsel should advise the clerk of court of scheduling conflicts for the next three court weeks, or thereafter. When filing the notice of conflicts, counsel should docket the Notice Regarding Conflicts with Argument Dates event, which is found in the Calendar event category. The notice of conflict with oral argument is due on or before 06/23/2017. [439993] [CAB] [Entered: 06/16/2017 01:26 PM] (0) |
| Jun 12, 2017 | 48 | JOINT APPENDIX, VOLS. I - XII FILED for Apotex Corp. and Apotex Inc. [43]. Number of Pages: 656. Service: 06/12/2017 by email. [439990] This appendix has been corrected. See Doc No. [57] [CAB] [Entered: 06/16/2017 01:16 PM] (0) |
| Jun 12, 2017 | 47 | CONFIDENTIAL JOINT APPENDIX, VOLS. I - XII FILED for Apotex Corp. and Apotex Inc. [44], [45], [46]. Number of Pages: 4933. Service: 06/12/2017 by email. The paper copies of the brief should be received by the court on or before 06/23/2017. [439985] This appendix has been corrected. See Doc No. [56] [CAB] [Entered: 06/16/2017 12:59 PM] (0) |
| Jun 12, 2017 | 46 | TENDERED from Appellants Apotex Corp., Apotex Inc. and Appellees Aptalis Pharmatech, Inc. and Ivax International GmbH. Title: CONFIDENTIAL JOINT APPENDIX Service: 06/12/2017 by email. [438456] This appendix has been corrected. See Doc No. [56] [William Zimmerman] [Entered: 06/12/2017 02:53 PM] (0) |
| Jun 12, 2017 | 45 | TENDERED from Appellants Apotex Corp., Apotex Inc. and Appellees Aptalis Pharmatech, Inc. and Ivax International GmbH. Title: CONFIDENTIAL JOINT APPENDIX Service: 06/12/2017 by email. [438446] This appendix has been corrected. See Doc No. [56] [William Zimmerman] [Entered: 06/12/2017 02:45 PM] (0) |
| Jun 12, 2017 | 44 | TENDERED from Appellants Apotex Corp., Apotex Inc. and Appellees Aptalis Pharmatech, Inc. and Ivax International GmbH. Title: CONFIDENTIAL JOINT APPENDIX Service: 06/12/2017 by email. [438443] This appendix has been corrected. See Doc No. [56] [William Zimmerman] [Entered: 06/12/2017 02:31 PM] (0) |
| Jun 12, 2017 | 43 | TENDERED from Appellants Apotex Corp., Apotex Inc. and Appellees Aptalis Pharmatech, Inc. and Ivax International GmbH. Title: JOINT APPENDIX. Service: 06/12/2017 by email. [438436] This appendix has been corrected. See Doc No. [57] [William Zimmerman] [Entered: 06/12/2017 02:15 PM] (0) |
| Jun 2, 2017 | 42 | 6 paper copies of the Reply Brief [34] received from Appellants Apotex Corp. and Apotex Inc. [435964] [JCP] [Entered: 06/02/2017 01:10 PM] (0) |
| Jun 1, 2017 | 40 | Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Appellants Apotex Corp. and Apotex Inc.. Service: 06/01/2017 by email. [435759] [William Zimmerman] [Entered: 06/01/2017 04:20 PM] (3) |
| Jun 1, 2017 | 41 | Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Appellees Aptalis Pharmatech, Inc. and Ivax International GmbH. Service: 06/01/2017 by email. [435798] [John Lane] [Entered: 06/01/2017 06:07 PM] (5) |
| Jun 1, 2017 | 39 | Statement of Compliance with Fed. Cir. R. 33 for Appellants Apotex Corp., Apotex Inc. and Appellees Aptalis Pharmatech, Inc. and Ivax International GmbH. Service: 06/01/2017 by email. [435755] [William Zimmerman] [Entered: 06/01/2017 04:19 PM] (3) |
| Jun 1, 2017 | 38 | **TEXT ONLY** ORDER granting motion to extend time to file appendix [37] filed by Appellants Apotex Inc. and Apotex Corp. Appendix is due 06/12/2017. Service as of this date by Clerk of Court. This order has been issued without an attached document and is official and binding. [435508] [FMS] [Entered: 06/01/2017 08:41 AM] (0) |
| May 31, 2017 | 37 | MOTION of Appellants Apotex Corp. and Apotex Inc. to extend the time to 06/12/2017 to file the appendix. Any response is due within 10 days of service [Consent: unopposed]. Service: 05/31/2017 by email. [435477] [Craig Summers] [Entered: 05/31/2017 05:35 PM] (8) |
| May 26, 2017 | 36 | Amended Entry of appearance for Thomas P. Krzeminski as of counsel for Appellants Apotex Corp. and Apotex Inc.. Service: 05/26/2017 by email. [434492] [Thomas Krzeminski] [Entered: 05/26/2017 01:09 PM] (2) |
| May 26, 2017 | 35 | REMINDER: All counsel of record are reminded of their responsibility per Fed. Cir. R. 47.3 to promptly submit an amended Entry of Appearance (EOA) as information changes during the pendency of the appeal. Failure to comply with these Rules may delay the timely processing of your case or result in adverse action. [CLERK'S NOTE: Contact information on ATTORNEY THOMAS P. KRZEMINSKI's entry of appearance does not match the information on his ECF filer account. ECF account information may be updated at www.pacer.gov, or counsel may file amended EOA reflecting the correct information.] [434315] [CAB] [Entered: 05/26/2017 09:12 AM] (0) |
| May 25, 2017 | 34 | REPLY BRIEF FILED for Appellants Apotex Corp. and Apotex Inc. [33]. Number of Pages: 34. Service: 05/25/2017 by email. The paper copies of the brief should be received by the court on or before 06/05/2017. Appendix is due 06/01/2017. [434312] [CAB] [Entered: 05/26/2017 09:08 AM] (42) |
| May 25, 2017 | 33 | TENDERED from Appellants Apotex Corp. and Apotex Inc.. Title: REPLY BRIEF. Service: 05/25/2017 by email. [434175] [William Zimmerman] [Entered: 05/25/2017 02:50 PM] (42) |
| May 23, 2017 | 32 | 6 paper copies of the Corrected Response Brief [29] received from Appellees Aptalis Pharmatech, Inc. and Ivax International GmbH. [433572] [KW] [Entered: 05/23/2017 02:26 PM] (0) |
| May 17, 2017 | 31 | Amended Entry of appearance for Susan E. Morrison as of counsel for Appellees Aptalis Pharmatech, Inc. and Ivax International GmbH. Service: 05/17/2017 by email. [432356] [Susan Morrison] [Entered: 05/17/2017 04:21 PM] (2) |
| May 17, 2017 | 30 | NOTICE OF DEFICIENCY: The attorney entry of appearance Document No. [27] filed by Appellees Aptalis Pharmatech, Inc. and Ivax International GmbH in 17-1344 is without a proper/complete proof of service and therefore cannot be accepted for filing at this time. You are being afforded the opportunity to correct the deficiency. At the discretion of the court, the corrected document may be accepted for filing if received before midnight (EST) on the date of this notice. [432256] [CAB] [Entered: 05/17/2017 01:30 PM] (0) |
| May 16, 2017 | 29 | CORRECTED BRIEF FILED for Appellees Aptalis Pharmatech, Inc. and Ivax International GmbH [28]. Number of Pages: 73. Service: 05/16/2017 by email. The paper copies of the brief should be received by the court on or before 05/24/2017. Appellants' reply brief is due 05/25/2017. [432253] [CAB] [Entered: 05/17/2017 01:27 PM] (86) |
| May 16, 2017 | 28 | TENDERED from Appellees Aptalis Pharmatech, Inc. and Ivax International GmbH. Title: CORRECTED RESPONSE BRIEF. Service: 05/16/2017 by email. [431951] [John Lane] [Entered: 05/16/2017 02:41 PM] (86) |
| May 16, 2017 | 27 | Amended Entry of appearance for Susan E. Morrison as of counsel for Appellees Aptalis Pharmatech, Inc. and Ivax International GmbH. Service: 05/16/2017 by email. [431856] [Susan Morrison] [Entered: 05/16/2017 12:10 PM] (0) |
| May 16, 2017 | 26 | REMINDER: All counsel of record are reminded of their responsibility per Fed. Cir. R. 47.4(a) and Fed. Cir. R. 47.3 to promptly submit an amended Certificate of Interest (COI) and/or Entry of Appearance (EOA) as information changes during the pendency of the appeal. Failure to comply with these Rules may delay the timely processing of your case or result in adverse action. [CLERK'S NOTE: The information on ATTORNEY SUSAN MORRISON COLETTI's entry of appearance does not match the information on counsel's ECF filer account. ECF account information may be updated at www.pacer.gov, or counsel may file amended EOA reflecting the correct information. [431815] [CAB] [Entered: 05/16/2017 11:31 AM] (0) |
| May 16, 2017 | 25 | NOTICE OF REJECTION: The brief of Appellees Aptalis Pharmatech, Inc. and Ivax International GmbH, Appellees' Responsive Brief [24], is not in compliance with the rules of this court and is therefore rejected for filing (see Notice for further details). Appellees corrected brief due 05/30/2017. Appellants' reply brief is due 05/25/2017. Service as of this date by Clerk of Court. [431801] [CAB] [Entered: 05/16/2017 11:21 AM] (1) |
| May 11, 2017 | 24 | TENDERED from Appellees Aptalis Pharmatech, Inc. and Ivax International GmbH. Title: RESPONSE BRIEF. Service: 05/11/2017 by email. [430852] This brief has been rejected. See Doc No. [25] [John Lane] [Entered: 05/11/2017 07:15 PM] (0) |
| Mar 10, 2017 | 23 | **TEXT ONLY** ORDER granting motion to extend time to file appellees' principal brief [22] filed by Appellees Aptalis Pharmatech, Inc. and Ivax International GmbH. Appellees' brief due 05/11/2017. Service as of this date by Clerk of Court. This order has been issued without an attached document and is official and binding. [414484] [CAB] [Entered: 03/10/2017 02:52 PM] (0) |
| Mar 9, 2017 | 22 | MOTION of Appellees Aptalis Pharmatech, Inc. and Ivax International GmbH to extend the time to 05/11/2017 to file the appellee/respondent/cross-appellant's principal brief. Any response is due within 10 days of service [Consent: unopposed]. Service: 03/09/2017 by email. [413975] [John Lane] [Entered: 03/09/2017 02:34 PM] (8) |
| Feb 27, 2017 | 21 | 6 paper copies of the Opening Brief [20] received from Appellants Apotex Corp. and Apotex Inc. [410873] [KW] [Entered: 02/27/2017 02:38 PM] (0) |
| Feb 15, 2017 | 20 | BRIEF FILED for Appellants Apotex Corp. and Apotex Inc. [19]. Number of Pages: 60. Service: 02/15/2017 by email. The paper copies of the brief should be received by the court on or before 03/01/2017. Appellees Aptalis Pharmatech, Inc. and Ivax International GmbH's brief is due 03/27/2017. [409594] [CAB] [Entered: 02/22/2017 11:34 AM] (131) |
| Feb 15, 2017 | 19 | TENDERED from Appellants Apotex Corp. and Apotex Inc.. Title: OPENING BRIEF. Service: 02/15/2017 by email. [407913] [William Zimmerman] [Entered: 02/15/2017 04:10 PM] (131) |
| Feb 7, 2017 | 18 | **TEXT ONLY** ORDER granting motion to extend time to file appellants' principal brief [17] filed by Appellants Apotex Inc. and Apotex Corp. Brief is due 02/17/2017. Service as of this date by Clerk of Court. This order has been issued without an attached document and is official and binding. [405238] [CAB] [Entered: 02/07/2017 12:47 PM] (0) |
| Feb 7, 2017 | 17 | MOTION of Appellants Apotex Corp. and Apotex Inc. to extend the time to 02/17/2017 to file the appellant/petitioner's principal brief. Any response is due within 10 days of service [Consent: unopposed]. Service: 02/07/2017 by email. [405181] [Thomas Krzeminski] [Entered: 02/07/2017 11:44 AM] (8) |
| Jan 31, 2017 | 16 | REMINDER: All counsel of record are reminded of their responsibility per Fed. Cir. R. 47.4(a)and Fed. Cir. R. 47.3 to promptly submit an amended Certificate of Interest (COI) and/or Entry of Appearance (EOA) as information changes during the pendency of the appeal. Failure to comply with these Rules may delay the timely processing of your case or result in adverse action. [403273] [CAB] [Entered: 01/31/2017 09:21 AM] (0) |
| Jan 23, 2017 | 15 | Entry of appearance for Karen M. Cassidy as of counsel for Appellants Apotex Corp. and Apotex Inc.. Service: 01/20/2017 by email. [400581] [Karen Cassidy] [Entered: 01/20/2017 07:03 PM] (2) |
| Dec 23, 2016 | 14 | Corrected Certificate of Interest for the Appellants Apotex Corp. and Apotex Inc.. Service: 12/23/2016 by email. [394266] [William Zimmerman] [Entered: 12/23/2016 12:56 PM] (2) |
| Dec 23, 2016 | 13 | NOTICE OF DEFICIENCY: The certificate of interest Document No. [3] filed by Appellants Apotex Inc. and Apotex Corp. in 17-1344 is incomplete [see question 2] and therefore cannot be accepted for filing at this time. Question two may not be left blank for any represented parties; if applicable, "none" may be used. You are being afforded the opportunity to correct the deficiency. At the discretion of the court, the corrected document may be accepted for filing if received before midnight (EST) on the date of this notice. [394188] [CMP] [Entered: 12/23/2016 10:50 AM] (0) |
| Dec 23, 2016 | 12 | Entry of appearance for Susan Morrison Coletti as of counsel for Appellees Aptalis Pharmatech, Inc. and Ivax International GmbH. Service: 12/23/2016 by email. [394159] [Susan Morrison] [Entered: 12/23/2016 10:15 AM] (2) |
| Dec 23, 2016 | 11 | Entry of appearance for Jonathan E. Singer as of counsel for Appellees Aptalis Pharmatech, Inc. and Ivax International GmbH. Service: 12/23/2016 by email. [394156] [Jonathan Singer] [Entered: 12/23/2016 10:12 AM] (2) |
| Dec 23, 2016 | 10 | Docketing Statement for the Appellees Aptalis Pharmatech, Inc. and Ivax International GmbH. Service: 12/23/2016 by email. [394154] [John Lane] [Entered: 12/23/2016 10:07 AM] (3) |
| Dec 23, 2016 | 9 | Certificate of Interest for the Appellee Ivax International GmbH. Service: 12/23/2016 by email. [394150] [John Lane] [Entered: 12/23/2016 10:05 AM] (2) |
| Dec 23, 2016 | 8 | Certificate of Interest for the Appellee Aptalis Pharmatech, Inc.. Service: 12/23/2016 by email. [394148] [John Lane] [Entered: 12/23/2016 10:04 AM] (2) |
| Dec 23, 2016 | 7 | Entry of appearance for John R. Lane as principal counsel for Appellees Aptalis Pharmatech, Inc. and Ivax International GmbH. Service: 12/23/2016 by email. [394145] [John Lane] [Entered: 12/23/2016 10:03 AM] (2) |
| Dec 22, 2016 | 6 | Entry of appearance for Thomas P. Krzeminski as of counsel for Appellants Apotex Corp. and Apotex Inc.. Service: 12/22/2016 by email. [393981] [Thomas Krzeminski] [Entered: 12/22/2016 06:44 PM] (2) |
| Dec 22, 2016 | 5 | Entry of appearance for Craig S. Summers as of counsel for Appellants Apotex Corp. and Apotex Inc.. Service: 12/22/2016 by email. [393978] [Craig Summers] [Entered: 12/22/2016 06:38 PM] (2) |
| Dec 22, 2016 | 4 | Docketing Statement for the Appellants Apotex Corp. and Apotex Inc.. Service: 12/22/2016 by email. [393977] [William Zimmerman] [Entered: 12/22/2016 06:32 PM] (4) |
| Dec 22, 2016 | 3 | Certificate of Interest for the Appellants Apotex Corp. and Apotex Inc.. Service: 12/22/2016 by email. [393976] [William Zimmerman] [Entered: 12/22/2016 06:29 PM] (0) |
| Dec 22, 2016 | 2 | Entry of appearance for William R. Zimmerman as principal counsel for Appellants Apotex Corp. and Apotex Inc.. Service: 12/22/2016 by email. [393975] [William Zimmerman] [Entered: 12/22/2016 06:28 PM] (2) |
| Dec 9, 2016 | 1 | Appeal docketed. Received: 12/08/2016. [389866]Entry of Appearance due 12/23/2016. Certificate of Interest is due on 12/23/2016. Docketing Statement due 12/23/2016. Appellants' brief is due 02/07/2017. [CAB] [Entered: 12/09/2016 04:10 PM] (22) |
